• Press Release

BIA welcomes new deal between Vertex and NHS England 

Steve Bates OBE, Chief Executive of the BIA said: “It’s fantastic to see the NHS and Vertex strike a lightning quick deal to enable NHS cystic fibrosis patients to access this important breakthrough therapy.

Investment in UK biotech remains strong latest data from the BIA shows

New figures published today (Monday 22 June 2020) by the UK BioIndustry Association (BIA) and Clarivate reveal that the UK biotech sector raised £585million from March to May 2020. A total of £894m has now been raised from all sources in the first half of 2020, surpassing the £831m raised in the same period in 2018, which was a record-breaking year.

£30 million Biomedical Catalyst to launch following successful BIA campaign

Innovative biotech companies will be able to access a share of £30 million in grant funding through a relaunched Biomedical Catalyst, Innovate UK’s CEO Ian Campbell confirmed today.

BIA welcomes new NIHR framework for restarting research activities in the UK

Commenting on the NIHR 'Framework for restart' released today, Steve Bates OBE, Chief Executive of the BIA said: 

BIA responds to government approach to Northern Ireland Protocol

Commenting on the Government’s approach to the Northern Ireland Protocol released yesterday, Steve Bates OBE, Chief Executive of the BioIndustry Association said:

BIA welcomes financial support for biotechs during COVID-19 disruption

A new support fund for innovative firms struggling to access equity finance during the COVID-19 disruption has opened for applications today (20 May). The Future Fund, run by the British Business Bank, will provide convertible loans of between £125,000 and £5m to businesses if they can also secure matched funding from third-party investors.

BIA responds to publication of draft UK-EU free trade agreement

Commenting on the publication of draft UK-EU free trade agreement text released today Steve Bates OBE, Chief Executive of the BIA said:

BIA responds to cash injection of €117m to eight coronavirus projects by the European Commission

Commenting on today’s announcement of €117 million awarded to eight coronavirus projects by the European Commission, Steve Bates OBE, Chief Executive of the BIA said:

Health Secretary pays tribute to UK life sciences companies, as testing ramps up for COVID-19

Commenting on the day of the 100,000 testing target, Steve Bates OBE, Chief Executive of the BIA said: “It’s gratifying to see the Government recognises the major role the UK life sciences industry has played in the collaborative, speedy and innovative national effort to increase testing capability.

BIA industry-led vaccine manufacturing taskforce welcomes collaboration announcement between AstraZeneca and the Jenner Institute on developing a COVID-19 vaccine

Steve Bates OBE, Chief Executive of the BIA said: “UK life sciences companies already working on key elements of manufacturing, through the BIA taskforce, look forward to working with AstraZeneca on the vital development and scale up of the Jenner COVID-19 vaccine.